About 101,000 results
Open links in new tab
FDA Approves Lilly's EBGLYSS™ (lebrikizumab-lbkz) for Adults …
FDA approves Ebglyss for moderate-to-severe atopic dermatitis
Lilly’s EBGLYSS gains FDA approval for patients aged 12 and older
FDA Approves Lilly's EBGLYSS™ (lebrikizumab-lbkz) for Adults …
Ebglyss, a New Biologic Treatment for Atopic Dermatitis, Gets FDA …
Health Canada Authorizes Lilly’s Ebglyss™
Treatment for Eczema | EBGLYSS™ (lebrikizumab-lbkz-lbkz)
New Eli Lilly Eczema Drug Brings Competition and Dosing Edge …
Lilly’s Ebglyss enters US atopic dermatitis market with FDA nod
Ebglyss Approved for Moderate to Severe Atopic Dermatitis
- Some results have been removed